Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes.

Authors:
Keur N; Saridaki M; Ricaño-Ponce I; Netea MG; Giamarellos-Bourboulis EJ and 1 more

Journal:
Respir Med

Publication Year: 2023

DOI:
10.1016/j.rmed.2023.107331

PMCID:
PMC10290733

PMID:
37364721

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Respir Med

Abbreviation: Respir Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Lung parenchymal abnormalities and outcomes in hospitalized patients with COVID 19 pneumonia: A pos…
Datta B; Prakash AK; Yaddanapudi K and 7 more (2023) - Transparency Score: 3/6
Lung ultrasound as a tool for monitoring the interstitial changes in recently hospitalised patients…
Loke TK; Earl N; Begbey ACH and 7 more (2023) - Transparency Score: 3/6
Multiple manifestations of uncontrolled asthma increase the risk of severe COVID-19.
Selberg S; Karlsson Sundbaum J; Konradsen JR and 4 more (2023) - Transparency Score: 3/6
Pneumothorax in hospitalized COVID-19 patients with severe respiratory failure: Risk factors and ou…
Ragnoli B; Cena T; Radaeli A and 5 more (2023) - Transparency Score: 1/6
Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid…
Patella V; Pelaia C; Zunno R and 1 more (2022) - Transparency Score: 1/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest All authors declare that they have no conflicts of interest."

Evidence found in paper:

"Funding This work was funded by the 10.13039/501100001826ZonMw (10430012010002) to VK. The SAVE study was funded by the Hellenic Institute for the Study of Sepsis, 10.13039/501100012112Swedish Orphan Biovitrum, and the 10.13039/100010661Horizon 2020 Framework Programme. (NCT04357366)"

Evidence found in paper:

"Trial registration NCT04357366."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025